Top compounds associated with response to AC009121.1


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC -0.041 0.4
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.058 0.05
mRNA tivantinib CTRPv2 pan-cancer AAC -0.0061 0.9
mRNA tivozanib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA tosedostat CTRPv2 pan-cancer AAC -0.043 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.05 0.08
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.025 0.5
mRNA triptolide CTRPv2 pan-cancer AAC -0.047 0.2
Download CSV